跳至主要内容
临床试验/NCT02036203
NCT02036203撤回不适用

A Prospective, Randomized, Single Blind, Two Arms Controlled Study of the Safety and Efficacy of the SCu300A IUB™ Spherical Copper Intrauterine Ball in Comparison to TCu 380 IUD Intra-uterine Contraceptive Device

Ocon Medical Ltd.1 个研究点 分布在 1 个国家开始时间: 2014年1月14日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Perforation rate

研究概览

简要总结

This study aims to evaluate the safety and efficacy of the IUB SCu300A spherical copper IUD compared to the standard T shaped copper IUD, the TCu380.

Participants will be followed for one year and quality of life measurements will be measured during this period as well.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
25 Years 至 42 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • * Adult females aged 25-42
  • Free and willing to fully comply with treatment process
  • Healthy women seeking LARC
  • Married or in a steady relationship (at least 1 year)
  • Blood hemoglobin >11.5gr%
  • Signed informed consent form
  • If took COCP at least had one cycle after use of OC
  • Exclusion Criteria(major)
  • Use IUB/IUD as an emergency contraception
  • A previously placed IUD that has not been removed
  • Pregnancy or suspicion of pregnancy
  • Use of other contraception method (condom for either male or female, oral contraceptives, diaphragms, spermicides, hormonal patches, injections or ring, cervical cap)
  • History of pelvic inflammatory disease, recent or remote.
  • Postpartum endometritis or post abortal endometritis in the past 3 month
  • Mucopurulent cervicitis
  • Endometrial thickness more than 12 mm on insertion date
  • Known anemia
  • History of previous IUD complications
  • Dysfunctional uterine bleeding
  • Undiagnosed uterine bleeding
  • Malignancy or suspected malignant disease of female inner or outer genitalia
  • Distortions of the uterine cavity by uterine fibroids or known anatomical abnormalities
  • Known intolerance or allergy to nitinol or copper and/or copper IUDs - Wilson's disease.
  • Medication that may interfere with the subject's ability to complete the protocol
  • Use of injectable contraception in the previous year
  • Any other significant disease or condition that could interfere with the subject's ability to complete the protocol
  • A history of alcohol or drug abuse
  • Known infection with human immunodeficiency virus (HIV), Hepatitis B or Hepatitis C
  • Pregnancy or pregnancy planned during the year
  • Enrollment (less than 30 days after completing another study) in or planned to be enrolled in another study

排除标准

  • 未提供

研究组 & 干预措施

SCu300A IUB

Experimental

干预措施: SCu300A IUB (Device)

TCu380A

Active Comparator

干预措施: TCu380A IUD (Device)

结局指标

主要结局

Perforation rate

时间窗: During device insertion

Number of subjects with partial or complete perforation through the uterine wall

Device expulsion

时间窗: 12 months

Number of subjects with partially or fully ejected devices

Efficacy in preventing pregnancy

时间窗: 12 months

Number of women who become pregnant during the trial period.

Device malposition

时间窗: 12 months

Number of subjects with observed device malposition within the uterine cavity

次要结局

  • Menorrhagia and dysmenorrhea rates(12 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验